Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
DJ Protagonist Therapeutics Is Maintained at Outperform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 03, 2021 05:16 ET (10:16 GMT)
DJ Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 03, 2021 05:16 ET (10:16 GMT)
DJ Protagonist Therapeutics Is Maintained at Outperform by SVB Leerink
DJ主角治疗公司由SVB Leerink维持在强于大盘的水平
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 03, 2021 05:16 ET (10:16 GMT)
2021年3月03日05:16美国东部时间(格林尼治标准时间10:16)
DJ Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
SVB Leerink将DJ主角治疗公司的目标价从每股30.00美元上调至41.00美元
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 03, 2021 05:16 ET (10:16 GMT)
2021年3月03日05:16美国东部时间(格林尼治标准时间10:16)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧